When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study

Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther. 2006; 11(1): 63-72.